HSNO application register
-
GMD02123
To include the application of RNA interference methodology to the study of neuroendocrine cell biology. Update of GMO00/UA055, GMO00/UA068, GM02/UA010
-
ERMA200918
To develop genetically modified bacterial and eukaryotic cell lines to examine the effects of new therapeutic treatments on the expression of genes involved in …
-
ERMA200787
To develop genetically modified Escherichia coli, yeast, mammalian, insect and fish cell lines to examine the therapeutic effects of new treatments on expressio…
-
GMD08038
To characterize processes for transport and signalling in biological membranes
-
APP201315
To develop genetically modified Escherichia coli, yeast and animal cell lines for cell-based assays and in vitro models to study the broad physiological interac…
-
GMD02006
To obtain retrospective approval for GMOs developed prior to the enhancement of the HSNO Act which may not have received ACNGT approval or for which ACNGT appro…
-
ERMA200732
To genetically modify Escherichia coli, yeast, viruses, cell lines and laboratory animals to study the effects of viral and cellular sequences and proteins
-
GMD06070
To develop in containment, using low-risk strains of organisms cells modified with gene expression vectors to express cloned proteins derived from a range of or…
-
ERMA200738
To develop genetically modified Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Caenorhabditis elegans and mammalian, fish and insect cell lines to…
-
GMD00328
To study the role of proteases and protease inhibitors in mammalian cells.